🇺🇸 FDA

Drug profile · INN

hydrochlorothiazide

LISINOPRIL AND HYDROCHLOROTHIAZIDE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

hydrochlorothiazide (LISINOPRIL AND HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN hydrochlorothiazide
Brand LISINOPRIL AND HYDROCHLOROTHIAZIDE
Route ORAL
Formulation CAPSULE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 10722581

    Phonophoretic cannabidiol composition and transdermal delivery system

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10398776

    Phonophoretic cannabidiol composition and transdermal delivery system

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9592291

    Methods for iontophoretically treating nausea and migraine

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9427578

    Pharmacokinetics of iontophoretic sumatriptan administration

    Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8530621

    Combined preparation of a thiazide diuretic and a loop diuretic

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8067636

    Dihydrazide compounds, preparation and uses thereof

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7888332

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is hydrochlorothiazide?

hydrochlorothiazide (LISINOPRIL AND HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for hydrochlorothiazide?

LISINOPRIL AND HYDROCHLOROTHIAZIDE is a marketed brand name for hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of hydrochlorothiazide?

hydrochlorothiazide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.